Combined Bleaching Technique: Efficacy and Tooth Sensitivity

NCT ID: NCT03089216

Last Updated: 2019-08-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-01

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this clinical study is to evaluate the efficacy and dental sensitivity associated with Combined Bleaching Technique (in-office + at-home) varying in-office bleaching application under two different time protocols, and dentifrice containing arginine 8% and carbonate calcium use. One hundred eight participants who meet the study inclusion criteria will be selected. The desensitizing agent used will be a dentifrice containing 8% arginine and calcium carbonate. In each evaluation will be determined: tooth sensitivity and color. The data collected will be submitted to the factorial statistical analysis for evaluation of color and chi-square test for tooth sensitivity (α = 5%).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted under the CONSORT recommendations. After approval by the Ethics Committee for Research duly registered, the trial will be conducted in the clinic of dental school at the Federal University of Goias located in Goiania. One hundred eight participants 108 volunteers will be selected on the criteria that qualify inclusion and exclusion from the study will be reported all volunteers were examined not qualify under the criteria for inclusion as part of the initial according to CONSORT recommendations .

After signing the signed an informed consent form all volunteer participants will receive a dental prophylaxis with pumice and water in a rubber cups for the removal of extrinsic stains two weeks before the beginning of tooth whitening.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tooth Bleaching Tooth Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Combined Bleaching(2x20)

In-office: 35% hydrogen peroxide of 20 minutes each. At-home: 10% carbamide peroxide

Group Type EXPERIMENTAL

Combined Bleaching(2x20)

Intervention Type PROCEDURE

one clinical session with two applications of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Combined Bleaching(2x20) with arginine

Combined Bleaching(2x20) with arginine In-office: 35% hydrogen peroxide of 20 minutes each. At-home: 10% carbamide peroxide Desensitizing agent: dentifrice containing 8% arginine and calcium carbonate.

Group Type EXPERIMENTAL

Combined Bleaching(2x20) with arginine

Intervention Type PROCEDURE

one clinical session with two applications of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

8% arginine and calcium carbonate

Intervention Type DRUG

using during all the treatment.

Combined Bleaching(1x20)

In-office: 35% hydrogen peroxide of 20 minutes each. At-home: 10% carbamide peroxide

Group Type EXPERIMENTAL

Combined Bleaching (1x20)

Intervention Type PROCEDURE

one clinical session with one application of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Combined Bleaching(1x20) with arginine

Combined Bleaching(1x20) with arginine In-office: 35% hydrogen peroxide of 20 minutes each. At-home: 10% carbamide peroxide Desensitizing agent: dentifrice containing 8% arginine and calcium carbonate.

Group Type EXPERIMENTAL

Combined Bleaching(1x20) with arginine

Intervention Type PROCEDURE

one clinical session with one application of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

8% arginine and calcium carbonate

Intervention Type DRUG

using during all the treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Combined Bleaching(2x20)

one clinical session with two applications of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Intervention Type PROCEDURE

Combined Bleaching(2x20) with arginine

one clinical session with two applications of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Intervention Type PROCEDURE

Combined Bleaching (1x20)

one clinical session with one application of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Intervention Type PROCEDURE

Combined Bleaching(1x20) with arginine

one clinical session with one application of 35% hydrogen peroxide of 20 minutes each. 10% carbamide peroxide for two hours daily over the course of two weeks.

Intervention Type PROCEDURE

8% arginine and calcium carbonate

using during all the treatment.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

dentifrice containing carbonate arginine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Upper and lower anterior teeth without restorations;
* Upper and lower anterior teeth that have never undergone a bleaching procedure and are A2 or darker in color compared to the Vita Classical).

Exclusion Criteria

* Presence of primary and/or secondary carious lesion (s) on upper and lower anterior teeth;
* Presence of non-carious lesions, such as abfraction, erosion and abrasion;
* Presence of clinically visible cracks or defects of dental enamel on the dental surfaces of the upper and lower anterior teeth;
* Use of fixed orthodontic appliances;
* Presence of tooth sensitivity classified as equal to or greater than mild;
* Presence of severe dental dimming;
* Presence of parafunctional habits;
* Presence of any oral pathology;
* Smokers;
* pregnant and lactating women
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Terezinha de Jesus Esteves Barata

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Terezinha de Jesus Esteves Barata

tde Jesus Esteves Barata

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Isabella N Favarão, DDS, MS

Role: PRINCIPAL_INVESTIGATOR

Universidade Federal de Goias

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

043178

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.